Texas Retina Associates
Welcome,         Profile    Billing    Logout  
 0 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wang, Robert
TYNI, NCT05486468: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

Recruiting
3
30
US
Yutiq 0.18 MG Drug Implant, Sham Injection
Texas Retina Associates, Eye Point Pharmaceuticals
Uveitis, Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate
12/23
12/24
LEOPARD, NCT05608837: Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects with Uveitis Related and Post Surgical Macular Edema

Recruiting
2
24
US
OCS-01, dexamethasone ophthalmic suspension eye drops
Quan Dong Nguyen, Global Ophthalmic Research Center (GORC), Oculis
Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative
07/25
09/25
NCT01191151: Web Based Orthopaedic Sports Medicine Registry

Terminated
N/A
12500
Europe, Canada, US, RoW
Arthrex, Inc.
Degenerative and Traumatic Pathology of the Knee, Degenerative and Traumatic Pathology of the Shoulder and Elbow, Degenerative and Traumatic Pathology of the Foot and Ankle, Degenerative and Traumatic Pathology of the Hand and Wrist, Degenerative and Traumatic Pathology of the Hip
07/23
07/23
Choi, Rene
TYNI, NCT05486468: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

Recruiting
3
30
US
Yutiq 0.18 MG Drug Implant, Sham Injection
Texas Retina Associates, Eye Point Pharmaceuticals
Uveitis, Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate
12/23
12/24
Creighton, Jodi
TYNI, NCT05486468: The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment

Recruiting
3
30
US
Yutiq 0.18 MG Drug Implant, Sham Injection
Texas Retina Associates, Eye Point Pharmaceuticals
Uveitis, Uveitis, Posterior, Uveitis, Anterior, Uveitis, Intermediate
12/23
12/24
SIGLEC, NCT05839041: A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Active, not recruiting
2
300
US
AVD-104, Avacincaptad
Aviceda Therapeutics, Inc.
Geographic Atrophy of the Macula, Macular Degeneration
09/25
09/26
Center, LEOPARD Coordinating
LEOPARD, NCT05608837: Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects with Uveitis Related and Post Surgical Macular Edema

Recruiting
2
24
US
OCS-01, dexamethasone ophthalmic suspension eye drops
Quan Dong Nguyen, Global Ophthalmic Research Center (GORC), Oculis
Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative
07/25
09/25
Or, Christopher
LEOPARD, NCT05608837: Multicenter Study on the Efficacy and Safety of OCS-01 in Subjects with Uveitis Related and Post Surgical Macular Edema

Recruiting
2
24
US
OCS-01, dexamethasone ophthalmic suspension eye drops
Quan Dong Nguyen, Global Ophthalmic Research Center (GORC), Oculis
Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative
07/25
09/25

Download Options